Measurement of glycine in the human brain in vivo by 1H-MRS at 3 T: Application in brain tumors

Magnetic Resonance in Medicine

Volumn 66, Issue 3, 2011, Pages 609-618

  Choi, Changho ^a   Ganji, Sandeep K ^a   Deberardinis, Ralph J ^a   Dimitrov, Ivan E ^a,b   Pascual, Juan M ^a   Bachoo, Robert ^a   Mickey, Bruce E ^a   Malloy, Craig R ^a,c   Maher, Elizabeth A ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b PHILIPS HEALTHCARE   (United States)

^c VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

3T; echo time optimization; glioblastoma; glycine; human brain; point resolved spectroscopy (PRESS)

Indexed keywords

BIOMOLECULES; BIOSYNTHESIS; BRAIN; MAGNETIC RESONANCE SPECTROSCOPY; METABOLITES; NUCLEIC ACIDS; TUMORS;

ECHO TIME; GLIOBLASTOMA MULTIFORME; GLIOBLASTOMAS; HUMAN BRAIN; METABOLIC INTERMEDIATES; METABOLITE CONCENTRATIONS; OPTIMUM SELECTIVITY; POINT RESOLVED SPECTROSCOPIES;

AMINO ACIDS;

CREATINE; GLYCINE; INOSITOL;

ARTICLE; BRAIN BIOPSY; BRAIN SLICE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IN VIVO STUDY; NEUROIMAGING; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL CORTEX; POINT RESOLVED SPECTROSCOPY; PROTEIN ANALYSIS; TIME LAPSE IMAGING; TUMOR VOLUME;

EID: 80051682583     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22857     Document Type: Article

References (38)

1. Govindaraju V, Young K, Maudsley AA,. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 2000; 13: 129-153. (Pubitemid 30414704)
2. Schulte RF, Boesiger P,. ProFit: two-dimensional prior-knowledge fitting of J-resolved spectra. NMR Biomed 2006; 19: 255-263.
3. 1H magnetic resonance spectroscopy at 4.0 T. Magn Reson Med 2006; 55: 681-686. (Pubitemid 43352569)
4. 1H-MRS in vivo at 3.0T. Magn Reson Med 2008; 59: 59-64.
5. 1H MRS in human brain at 7 T. MAGMA 2009; 22: 1-4.
6. Choi C, Douglas D, Hawesa H, Jindal A, Storey C, Dimitrov I,. Measurement of glycine in human prefrontal brain by point-resolved spectroscopy at 7.0 tesla in vivo. Magn Reson Med 2009; 62: 1305-1310.
7. Legendre P,. The glycinergic inhibitory synapse. Cell Mol Life Sci 2001; 58: 760-793. (Pubitemid 32553033)
8. Eulenburg V, Armsen W, Betz H, Gomeza J,. Glycine transporters: essential regulators of neurotransmission. Trends Biochem Sci 2005; 30: 325-333. (Pubitemid 40799051)
9. Javitt DC,. Glutamate and schizophrenia: phencyclidine, N-methyl-d-aspartate receptors, and dopamine-glutamate interactions. Int Rev Neurobiol 2007; 78: 69-108.
10. Kaufman MJ, Prescot AP, Ongur D, Evins AE, Barros TL, Medeiros CL, Covell J, Wang L, Fava M, Renshaw PF,. Oral glycine administration increases brain glycine/creatine ratios in men: a proton magnetic resonance spectroscopy study. Psychiatry Res 2009; 173: 143-149.
11. Gill SS, Thomas DG, Van Bruggen N, Gadian DG, Peden CJ, Bell JD, Cox IJ, Menon DK, Iles RA, Bryant DJ, Coutts GA,. Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies. J Comput Assist Tomogr 1990; 14: 497-504. (Pubitemid 20217153)
12. Bruhn H, Michaelis T, Merboldt KD, Hanicke W, Gyngell ML, Hamburger C, Frahm J,. On the interpretation of proton NMR spectra from brain tumours in vivo and in vitro. NMR Biomed 1992; 5: 253-258.
13. 1H NMR spectroscopy for three types of human brain and nervous system tumours. NMR Biomed 1995; 8: 253-264.
14. Kinoshita Y, Yokota A,. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. NMR Biomed 1997; 10: 2-12. (Pubitemid 27346611)
15. 1H MRS study of human high grade gliomas. NMR Biomed 2004; 17: 191-205. (Pubitemid 39089246)
16. 1H NMR spectroscopic investigation. NMR Biomed 2005; 18: 371-382. (Pubitemid 41410357)
17. Yeh IB, Xu M, Ng WH, Ye J, Yang D, Lim CC,. Central neurocytoma: typical magnetic resonance spectroscopy findings and atypical ventricular dissemination. Magn Reson Imaging 2008; 26: 59-64. (Pubitemid 350299720)
18. 1H MR spectroscopic imaging with short and long echo time to discriminate glycine in glial tumours. MAGMA 2009; 22: 33-41.
19. 1H MRS at 1.5 tesla confirmed by ex-vivo high-resolution magic-angle spinning NMR. NMR Biomed 2010; 23: 80-87.
20. Choi CG, Lee HK, Yoon JH,. Localized proton MR spectroscopic detection of nonketotic hyperglycinemia in an infant. Korean J Radiol 2001; 2: 239-242. (Pubitemid 33688974)
21. Huisman TA, Thiel T, Steinmann B, Zeilinger G, Martin E,. Proton magnetic resonance spectroscopy of the brain of a neonate with nonketotic hyperglycinemia: in vivo-in vitro (ex vivo) correlation. Eur Radiol 2002; 12: 858-861. (Pubitemid 36940145)
22. Gruetter R,. Automatic, localized in vivo adjustment of all first- and second-order shim coils. Magn Reson Med 1993; 29: 804-811. (Pubitemid 23182863)
23. 1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy. J Magn Reson B 1994; 104: 1-10.
24. Klose U,. In vivo proton spectroscopy in presence of eddy currents. Magn Reson Med 1990; 14: 26-30. (Pubitemid 20243862)
25. Provencher SW,. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672-679. (Pubitemid 23360802)
26. 2 relaxation times of human brain metabolites at 3 Tesla. NMR Biomed 2001; 14: 325-331. (Pubitemid 32782846)
27. 2 values in normal brain and determination of regional differences in transverse relaxation. J Magn Reson Imaging 2004; 19: 537-545. (Pubitemid 38619915)
28. Choi C, Coupland NJ, Bhardwaj PP, Kalra S, Casault CA, Reid K, Allen PS,. T2 measurement and quantification of glutamate in human brain in vivo. Magn Reson Med 2006; 56: 971-977. (Pubitemid 44691338)
29. 1H NMR spectroscopy of the human brain at high magnetic fields: metabolite quantification at 4T vs. 7T. Magn Reson Med 2009; 62: 868-879.
30. Nikiforov MA, Chandriani S, O'Connell B, Petrenko O, Kotenko I, Beavis A, Sedivy JM, Cole MD,. A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism. Mol Cell Biol 2002; 22: 5793-5800. (Pubitemid 34815828)
31. Keevil SF, Barbiroli B, Brooks JC, Cady EB, Canese R, Carlier P, Collins DJ, Gilligan P, Gobbi G, Hennig J, Kugel H, Leach MO, Metzler D, Mlynarik V, Moser E, Newbold MC, Payne GS, Ring P, Roberts JN, Rowland IJ, Thiel T, Tkac I, Topp S, Wittsack HJ, Wylezinska M, Zaniol P, Henriksen O, Podo F,. Absolute metabolite quantification by in vivo NMR spectroscopy. II. A multicentre trial of protocols for in vivo localised proton studies of human brain. Magn Reson Imaging 1998; 16: 1093-1106. (Pubitemid 29189665)
32. Tong Z, Yamaki T, Harada K, Houkin K,. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard. Magn Reson Imaging 2004; 22: 1017-1024. (Pubitemid 38993532)
33. Barker PB, Breiter SN, Soher BJ, Chatham JC, Forder JR, Samphilipo MA, Magee CA, Anderson JH,. Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations. Magn Reson Med 1994; 32: 157-163. (Pubitemid 24243294)
34. Choi C, Coupland NJ, Kalra S, Bhardwaj PP, Malykhin N, Allen PS,. Proton spectral editing for discrimination of lactate and threonine 1.31 ppm resonances in human brain in vivo. Magn Reson Med 2006; 56: 660-665. (Pubitemid 44338886)
35. Marjanska M, Henry PG, Ugurbil K, Gruetter R,. Editing through multiple bonds: threonine detection. Magn Reson Med 2008; 59: 245-251. (Pubitemid 351220087)
36. Kotitschke K, Jung H, Nekolla S, Haase A, Bauer A, Bogdahn U,. High-resolution one- and two-dimensional 1H MRS of human brain tumor and normal glial cells. NMR Biomed 1994; 7: 111-120. (Pubitemid 2088958)
37. Slotboom J, Mehlkope AF, Bovee WMMJ,. The effects of frequency-selective RF pulses on J-coupled spin-1/2 systems. J Magn Reson A 1994; 108: 38-50.
38. 1H MR spectroscopy. J Magn Reson 2008; 195: 67-75.